Association of depression and impulse control disorder in patients with parkinson's disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033009

Enrollment

Unknown

Registered

2020-05-17

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The diagnosis of Parkinson's disease in accordance with the 2015 MDS clinical diagnostic criteria; 2. QUIP-RS score = 0; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Secondary Parkinson's syndrome or Parkinson-Plus Syndrome due to vascular factors, toxins, drugs, etc.; 2. Previous intracranial surgery (including nerve nucleus destruction and deep brain stimulation); 3. Combining unconsciousness, severe coronary heart disease, diabetes, liver and kidney disease, and severe vision and hearing impairment; 4. Taking antidepressants without diagnosis of depressive symptoms, and GDS-15 score <= 7.

Design outcomes

Primary

Measure	Time frame
depression score;impulse control disorder;	—

Countries

China

Contacts

Public ContactPuqing Wang

Xiangyang No.1 People's Hospital, Affliated Hospital of Hubei University of Medicine

wpq20110328@qq.com+86 15072288918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026